Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification-Reference-Cited by-同舟云学术

Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification

Published:2023-06 Issue: Volume:186 Page:98-112
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Perrone Emanuele,Capasso Ilaria,De Felice Francesca,Giannarelli Diana,Dinoi Giorgia,Petrecca Alessandro,Palmieri Luca^ORCID,Foresta Aniello^ORCID,Nero Camilla,Arciuolo Damiano,Lorusso Domenica,Zannoni Gian Franco,Scambia Giovanni,Fanfani Francesco

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference39 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022

2. Paclitaxel, carboplatin, and bevacizumab in advanced and recurrent endometrial carcinoma;Rose;Int J Gynecol Cancer,2017

3. Laparoscopic vs. robotic-assisted laparoscopy in endometrial cancer staging: large retrospective single-institution study;Perrone;J Gynecol Oncol,2021

4. Two pathogenetic types of endometrial carcinoma;Bokhman;Gynecol Oncol,1983

5. Two distinct tumorigenic processes in endometrial endometrioid adenocarcinoma;Sugiyama;Am J Pathol,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unsolved Issues in the Integrated Histo-Molecular Classification of Endometrial Carcinoma and Therapeutic Implications;Cancers;2024-07-04

2. Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer;International Journal of Gynecologic Cancer;2024-02-20

3. Redefining the Position of Hormonal Therapy in Endometrial Cancer in the Era of Molecular Classification;Journal of Clinical Oncology;2024-01-01